This BIO PE ratio history page last updated 4/19/2024
Period | Price | Adj. EPS | TTM | PE |
Q4 2023 2/15/2024 | 328.73 | 3.10 | 11.77 | 27.9 | Q3 2023 10/26/2023 | 291.53 | 2.33 | 11.98 | 24.3 | Q2 2023 8/3/2023 | 401.80 | 3.00 | 12.25 | 32.8 | Q1 2023 5/4/2023 | 462.61 | 3.34 | 12.63 | 36.6 | Q4 2022 2/16/2023 | 455.91 | 3.31 | 14.23 | 32.0 | Q3 2022 10/27/2022 | 385.02 | 2.60 | 14.13 | 27.2 | Q2 2022 7/28/2022 | 559.86 | 3.38 | 15.24 | 36.7 | Q1 2022 4/28/2022 | 513.11 | 4.94 | 15.40 | 33.3 | Q4 2021 2/10/2022 | 625.17 | 3.21 | 15.67 | 39.9 | Q3 2021 10/28/2021 | 788.82 | 3.71 | 16.47 | 47.9 | Q2 2021 7/29/2021 | 707.13 | 3.54 | 15.76 | 44.9 | Q1 2021 4/29/2021 | 640.73 | 5.21 | 13.83 | 46.3 | Q4 2020 2/11/2021 | 643.81 | 4.01 | 10.53 | 61.1 | Q3 2020 10/29/2020 | 568.03 | 3.00 | 8.84 | 64.3 | Q2 2020 7/30/2020 | 535.60 | 1.61 | 7.45 | 71.9 | Q1 2020 5/6/2020 | 449.99 | 1.91 | 7.41 | 60.7 | Q4 2019 2/13/2020 | 379.34 | 2.32 | 7.15 | 53.1 | Q3 2019 10/31/2019 | 331.62 | 1.61 | 6.96 | 47.6 | Q2 2019 8/1/2019 | 310.37 | 1.57 | 6.26 | 49.6 | Q1 2019 5/8/2019 | 296.51 | 1.65 | 6.33 | 46.8 | Q4 2018 2/28/2019 | 270.90 | 2.13 | 5.85 | 46.3 | Q3 2018 11/1/2018 | 275.34 | 0.91 | 5.22 | 52.7 | Q2 2018 8/7/2018 | 308.97 | 1.64 | 5.22 | 59.2 | Q1 2018 5/8/2018 | 253.69 | 1.17 | 3.75 | 67.7 | Q4 2017 2/27/2018 | 254.00 | 1.50 | 3.20 | 79.4 | Q3 2017 11/2/2017 | 216.94 | 0.91 | 2.48 | 87.5 | Q2 2017 8/3/2017 | 242.28 | 0.17 | 2.19 | 110.6 | Q1 2017 5/4/2017 | 220.77 | 0.62 | 3.04 | 72.6 | Q4 2016 2/23/2017 | 192.00 | 0.78 | 2.84 | 67.6 | Q3 2016 11/1/2016 | 155.52 | 0.62 | 3.74 | 41.6 | Q2 2016 8/3/2016 | 145.77 | 1.02 | 3.71 | 39.3 | Q1 2016 5/5/2016 | 143.39 | 0.42 | 3.81 | 37.6 | Q4 2015 2/25/2016 | 132.05 | 1.68 | 4.00 | 33.0 | Q3 2015 11/3/2015 | 141.32 | 0.59 | 3.66 | 38.6 | Q2 2015 8/6/2015 | 144.71 | 1.12 | 3.46 | 41.8 | Q1 2015 5/5/2015 | 134.69 | 0.61 | 3.43 | 39.3 | Q4 2014 2/26/2015 | 119.00 | 1.34 | 3.05 | 39.0 | Q3 2014 11/4/2014 | 111.80 | 0.39 | 2.75 | 40.7 | Q2 2014 8/5/2014 | 116.18 | 1.09 | 2.11 | 55.1 | Q1 2014 5/6/2014 | 124.19 | 0.23 | 2.22 | 55.9 | Q4 2013 2/27/2014 | 130.97 | 1.04 | 2.67 | 49.1 | Q3 2013 11/7/2013 | 123.61 | -0.25 | 3.28 | 37.7 | Q2 2013 8/6/2013 | 123.40 | 1.20 | 5.01 | 24.6 | Q1 2013 5/7/2013 | 111.66 | 0.68 | 5.50 | 20.3 | Q4 2012 2/26/2013 | 117.30 | 1.65 | 5.91 | 19.8 | Q3 2012 11/6/2012 | 103.25 | 1.48 | NA | NA | Q2 2012 8/7/2012 | 98.25 | 1.69 | NA | NA | Q1 2012 5/1/2012 | 108.15 | 1.09 | NA | NA |
|
Period | Price | Adj. EPS | Annualized | PE |
Q4 2023 2/15/2024 | 328.73 | 3.10 | 12.40 | 26.5 | Q3 2023 10/26/2023 | 291.53 | 2.33 | 9.32 | 31.3 | Q2 2023 8/3/2023 | 401.80 | 3.00 | 12.00 | 33.5 | Q1 2023 5/4/2023 | 462.61 | 3.34 | 13.36 | 34.6 | Q4 2022 2/16/2023 | 455.91 | 3.31 | 13.24 | 34.4 | Q3 2022 10/27/2022 | 385.02 | 2.60 | 10.40 | 37.0 | Q2 2022 7/28/2022 | 559.86 | 3.38 | 13.52 | 41.4 | Q1 2022 4/28/2022 | 513.11 | 4.94 | 19.76 | 26.0 | Q4 2021 2/10/2022 | 625.17 | 3.21 | 12.84 | 48.7 | Q3 2021 10/28/2021 | 788.82 | 3.71 | 14.84 | 53.2 | Q2 2021 7/29/2021 | 707.13 | 3.54 | 14.16 | 49.9 | Q1 2021 4/29/2021 | 640.73 | 5.21 | 20.84 | 30.7 | Q4 2020 2/11/2021 | 643.81 | 4.01 | 16.04 | 40.1 | Q3 2020 10/29/2020 | 568.03 | 3.00 | 12.00 | 47.3 | Q2 2020 7/30/2020 | 535.60 | 1.61 | 6.44 | 83.2 | Q1 2020 5/6/2020 | 449.99 | 1.91 | 7.64 | 58.9 | Q4 2019 2/13/2020 | 379.34 | 2.32 | 9.28 | 40.9 | Q3 2019 10/31/2019 | 331.62 | 1.61 | 6.44 | 51.5 | Q2 2019 8/1/2019 | 310.37 | 1.57 | 6.28 | 49.4 | Q1 2019 5/8/2019 | 296.51 | 1.65 | 6.60 | 44.9 | Q4 2018 2/28/2019 | 270.90 | 2.13 | 8.52 | 31.8 | Q3 2018 11/1/2018 | 275.34 | 0.91 | 3.64 | 75.6 | Q2 2018 8/7/2018 | 308.97 | 1.64 | 6.56 | 47.1 | Q1 2018 5/8/2018 | 253.69 | 1.17 | 4.68 | 54.2 | Q4 2017 2/27/2018 | 254.00 | 1.50 | 6.00 | 42.3 | Q3 2017 11/2/2017 | 216.94 | 0.91 | 3.64 | 59.6 | Q2 2017 8/3/2017 | 242.28 | 0.17 | 0.68 | 356.3 | Q1 2017 5/4/2017 | 220.77 | 0.62 | 2.48 | 89.0 | Q4 2016 2/23/2017 | 192.00 | 0.78 | 3.12 | 61.5 | Q3 2016 11/1/2016 | 155.52 | 0.62 | 2.48 | 62.7 | Q2 2016 8/3/2016 | 145.77 | 1.02 | 4.08 | 35.7 | Q1 2016 5/5/2016 | 143.39 | 0.42 | 1.68 | 85.4 | Q4 2015 2/25/2016 | 132.05 | 1.68 | 6.72 | 19.7 | Q3 2015 11/3/2015 | 141.32 | 0.59 | 2.36 | 59.9 | Q2 2015 8/6/2015 | 144.71 | 1.12 | 4.48 | 32.3 | Q1 2015 5/5/2015 | 134.69 | 0.61 | 2.44 | 55.2 | Q4 2014 2/26/2015 | 119.00 | 1.34 | 5.36 | 22.2 | Q3 2014 11/4/2014 | 111.80 | 0.39 | 1.56 | 71.7 | Q2 2014 8/5/2014 | 116.18 | 1.09 | 4.36 | 26.6 | Q1 2014 5/6/2014 | 124.19 | 0.23 | 0.92 | 135.0 | Q4 2013 2/27/2014 | 130.97 | 1.04 | 4.16 | 31.5 | Q3 2013 11/7/2013 | 123.61 | -0.25 | -1.00 | NA | Q2 2013 8/6/2013 | 123.40 | 1.20 | 4.80 | 25.7 | Q1 2013 5/7/2013 | 111.66 | 0.68 | 2.72 | 41.1 | Q4 2012 2/26/2013 | 117.30 | 1.65 | 6.60 | 17.8 | Q3 2012 11/6/2012 | 103.25 | 1.48 | 5.92 | 17.4 | Q2 2012 8/7/2012 | 98.25 | 1.69 | 6.76 | 14.5 | Q1 2012 5/1/2012 | 108.15 | 1.09 | 4.36 | 24.8 |
|
On this page we presented the BIO PE Ratio History information for Bio-Rad Laboratories' stock.
The average BIO PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 52.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BIO PE ratio history based on this TTM earnings result method is 47.6. Note: any PE calculations involving negative earnings were discarded as not meaningful.
Let's now compare this BIO PE ratio history result, against the recent PE: when this page was posted on 4/18/2024, the most recent closing price for BIO had been 281.02, and the most recent quarterly earnings result, annualized, was 12.4. Meanwhile, the most recent TTM earnings summed to 11.77. From these numbers, we calculate the recent BIO PE on 4/18/2024 based on annualized quarterly EPS was 22.7. Based on BIO's history, that recent PE is low relative to the historical average, with the recent PE 56.6% lower than the historical average PE across our data set for Bio-Rad Laboratories. Looking at the recent BIO PE on 4/18/2024 based on TTM EPS, we calculate the ratio at 23.9. Based on BIO's history, that recent PE is low relative to the historical average, with the recent PE 49.8% lower than the average PE across our Bio-Rad Laboratories data set with TTM EPS used in the calculation at each period.
Another interesting BIO PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for BIO, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for BIO, we start with the past four EPS numbers and we first sort them from lowest to highest: 2.33, 3.00, 3.10, and 3.34. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 3.00 and 3.10 — which gives us the median of 3.05. Basically the way to think about this 3.05 number is this: for the trailing four earnings reports, 3.05 marks the "middle ground" number where BIO has reported a value higher than 3.05 half the time, and has reported a value lower than 3.05 half the time. Annualizing that median value then gets us to 12.2/share, which we use as the denominator in our next PE calculation. With 281.02 as the numerator (as of 4/18/2024), the calculation is then 281.02 / 12.2 = 23.0 as the BIO PE ratio as of 4/18/2024, based on that annualized median value we calculated.
For self directed investors doing their due diligence on BIO or any other given stock, valuation analysis for BIO
can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can
help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios
justify the current stock market value.
That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate
Bio-Rad Laboratories PE ratio history — or the PE history for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for
next earnings dates and also historical earnings surprises history for BIO. Thanks for visiting, and the next
time you need to research BIO PE Ratio History or the PE ratio history for another stock, we hope our site
will come to mind as your go-to PE ratio history research resource of choice.